-
EP3659594
European procedure
Extract from the Register of European Patents
EP About this file: EP3659594
| EP3659594 - A STERILE SOLUTION WITH AN APPLICATION INJECTOR COMPRISING A MEDICAL AGENT AND METHOD FOR PRODUCING SAME [Right-click to bookmark this link] | Status | The patent has been granted Status updated on 16.10.2020 Database last updated on 03.05.2025 | |
| Former | Grant of patent is intended Status updated on 24.06.2020 | ||
| Former | Request for examination was made Status updated on 01.05.2020 | Most recent event Tooltip | 22.10.2024 | Change: Date of oral proceedings | 22.10.2024 | Deletion: Despatch of minutes of oral proceedings | Applicant(s) | For all designated states Stegemann, Klaus Hackmackbogen 82 21035 Hamburg / DE | [2020/23] | Inventor(s) | 01 /
see applicant ... | [2020/23] | Representative(s) | Raffay & Fleck Patentanwälte Stephansplatz 2-6 20354 Hamburg / DE | [N/P] |
| Former [2020/23] | Raffay & Fleck Patentanwälte Grosse Bleichen 8 20354 Hamburg / DE | Application number, filing date | 18209583.6 | 30.11.2018 | [2020/23] | Filing language | DE | Procedural language | DE | Publication | Type: | A1 Application with search report | No.: | EP3659594 | Date: | 03.06.2020 | Language: | DE | [2020/23] | Type: | B1 Patent specification | No.: | EP3659594 | Date: | 18.11.2020 | Language: | DE | [2020/47] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 03.07.2019 | Classification | IPC: | A61K31/216, A61M5/178, // A61K9/08 | [2020/23] | CPC: |
A61K31/216 (EP);
A61M5/3134 (EP,US);
A61M5/315 (US);
A61K9/0019 (EP);
A61M2005/3104 (EP,US);
A61M2202/0007 (US);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2020/35] |
| Former [2020/23] | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR | Extension states | BA | 05.10.2020 | ME | 05.10.2020 | Title | German: | EINE STERILE LÖSUNG MIT EINEM MEDIZINISCHEN WIRKSTOFF ENTHALTENDE APPLIKATIONSSPRITZE UND VERFAHREN FÜR DEREN BEREITSTELLUNG | [2020/23] | English: | A STERILE SOLUTION WITH AN APPLICATION INJECTOR COMPRISING A MEDICAL AGENT AND METHOD FOR PRODUCING SAME | [2020/23] | French: | SERINGUE D'ADMINISTRATION DE SOLUTION STÉRILE COMPORTANT UNE SUBSTANCE ACTIVE MÉDICALE ET SON PROCÉDÉ D'UTILISATION | [2020/23] | Examination procedure | 05.12.2019 | Amendment by applicant (claims and/or description) | 05.12.2019 | Examination requested [2020/23] | 05.12.2019 | Date on which the examining division has become responsible | 25.06.2020 | Communication of intention to grant the patent | 21.07.2020 | Fee for grant paid | 21.07.2020 | Fee for publishing/printing paid | 21.07.2020 | Receipt of the translation of the claim(s) | Opposition(s) | Opponent(s) | 01
18.08.2021
Hepp Wenger Ryffel AG Friedtalweg 5 9500 Wil / CH Opponent's representative Hepp Wenger Ryffel AG Friedtalweg 5 9500 Wil / CH | [2021/38] | 30.08.2021 | Invitation to proprietor to file observations on the notice of opposition | 10.01.2022 | Reply of patent proprietor to notice(s) of opposition | 02.03.2023 | Date of oral proceedings | 30.05.2023 | Despatch of interlocutory decision in opposition | 30.05.2023 | Despatch of minutes of oral proceedings | Appeal following opposition | 21.07.2023 | Appeal received No. T1366/23 | 21.07.2023 | Payment of appeal fee | 06.10.2023 | Statement of grounds filed | 28.07.2023 | Appeal received No. T1366/23 | 28.07.2023 | Payment of appeal fee | 21.09.2023 | Statement of grounds filed | 30.09.2025 | Date of oral proceedings |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | AL | 18.11.2020 | MC | 18.11.2020 | MT | 18.11.2020 | SM | 18.11.2020 | PT | 31.08.2022 | [2022/48] |
| Former [2022/29] | AL | 18.11.2020 | |
| MC | 18.11.2020 | ||
| MT | 18.11.2020 | ||
| SM | 18.11.2020 | ||
| Former [2021/45] | AL | 18.11.2020 | |
| MC | 18.11.2020 | ||
| SM | 18.11.2020 | ||
| Former [2021/40] | MC | 18.11.2020 | |
| SM | 18.11.2020 | ||
| Former [2021/32] | SM | 18.11.2020 | Documents cited: | Search | [Y]WO2012166045 (CATHEASY VAESTERAAS AB [SE], et al); | [Y]WO2014131742 (OTTO ULLRICH [DE]); | [XY]US2016058715 (RAKESH THUMMAR [IN], et al); | [A]WO2016187078 (CARILION CLINIC [US]); | [A]WO2017085253 (FORMYCON AG [DE]); | Opposition | ES27122U | US2703575 | DE3106988 | JPS6055447U | EP0326361 | EP0390244 | WO9512482 | DE4438360 | JP2000116780 | US6065270 | DE10201110 | JP2004018379 | DE69814575T | EP1442762 | WO2004075958 | CN2899813Y | WO2012166045 | DE102011107764 | EP2594206 | WO2013184270 | US2014025017 | WO2014131742 | WO2014134577 | WO2015033349 | US2016058715 | EP3061477 | WO2016187078 | WO2017085253 | WO2017209800 | EP3338839 | WO2018122366 | WO2019151578 |